84 results match your criteria: "Manhattan Veterans Affairs Medical Center.[Affiliation]"
Urol Oncol
December 2024
Department of Urology, Yale School of Medicine, New Haven, CT; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT; Yale Cancer Outcomes, Public Policy and Effectiveness Research Center, New Haven, CT. Electronic address:
Background And Objective: As most Prostate Imaging Reporting and Data System (PI-RADS) 5 lesions on MRI harbor Gleason grade (GG) group ≥2 disease on biopsy, optimal management of patients with imaging-biopsy discordance remains unclear. To estimate grade misclassification, we evaluated the incidence of Gleason upgrading among patients with GG1 disease in the setting of a PI-RADS 5 lesion.
Methods: We conducted a single-institution retrospective analysis to identify patients with GG1 prostate cancer on fusion biopsy with MRI demonstrating ≥1 PI-RADS 5 lesion.
JAMA
December 2024
Yale Cancer Outcomes, Public Policy, and Effectiveness Research Center, New Haven, Connecticut.
Urol Pract
October 2024
Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Urol Pract
November 2024
Department of Urology, Yale School of Medicine, New Haven, Connecticut.
Introduction: Although prostate MRI and tissue-based gene expression (genomic) tests improve staging and estimates of prostate cancer prognosis, their association with the intensity of treatment patients receive is not well understood.
Methods: We performed a retrospective cohort study of Medicare beneficiaries diagnosed with clinically localized prostate cancer in 2013 through 2017 in the Surveillance, Epidemiology, and End Results database. The primary study outcome was the receipt of treatment intensification in the first 12 months after diagnosis (defined as the addition of androgen deprivation therapy among patients receiving radiation or pelvic lymphadenectomy among those undergoing radical prostatectomy).
J Endourol
October 2024
Department of Urology, New York University Grossman School of Medicine, New York, New York, USA.
Kidney stones are common and morbid conditions in the general population with a rising incidence globally. Previous studies show substantial limitations of online sources of information regarding prevention and treatment. The objective of this study was to examine the quality of information on kidney stones from artificial intelligence (AI) chatbots.
View Article and Find Full Text PDFCA Cancer J Clin
September 2024
Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.
BJUI Compass
June 2024
Yale Cancer Outcomes, Public Policy, and Effectiveness Research Center New Haven Connecticut USA.
Introduction: Although prostate magnetic resonance imaging (MRI) is commonly used in the diagnosis, staging and active surveillance of prostate cancer, little is known about patient perspectives on MRI.
Methods: We performed a qualitative study consisting of in-depth, semi-structured interviews of patients with low- and intermediate-risk prostate cancer managed with active surveillance. Interviews focused on experiences with and knowledge of prostate MRI and MRI-ultrasound fusion biopsy during active surveillance.
Background: Tissue-based gene expression (genomic) tests provide estimates of prostate cancer aggressiveness and are increasingly used for patients considering or engaged in active surveillance. However, little is known about patient experiences with genomic testing and its role in their decision-making.
Methods: We performed a qualitative study consisting of in-depth, semi-structured interviews of patients with low- or favourable-intermediate-risk prostate cancer managed with active surveillance.
Nat Rev Urol
June 2024
Department of Surgery (Urology Service), Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Decisions around prostate-specific antigen screening require a patient-centred approach, considering the benefits and risks of potential harm. Using shared decision-making (SDM) can improve men's knowledge and reduce decisional conflict. SDM is supported by evidence, but can be difficult to implement in clinical settings.
View Article and Find Full Text PDFUrol Pract
September 2023
Department of Urology, University of Maryland, Baltimore, Maryland.
Introduction: We sought to assess the quality, understandability, actionability, and diversity of speakers in videos on TikTok and YouTube regarding overactive bladder.
Methods: Using Application Program Interface, the top 500 TikTok and 120 YouTube videos on overactive bladder were retrieved. Videos unrelated to overactive bladder, those not in English, longer than 10 minutes, or lacking both text and audio were excluded.
Urol Pract
May 2022
Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
JNCI Cancer Spectr
March 2023
Genesis Healthcare Partners, San Diego, CA, USA.
Objectives: This study aimed to evaluate content quality and racial/ethnic representation, particularly of high-risk cohorts, of prostate cancer screening videos on YouTube (YT) and TikTok (TK).
Materials And Methods: The top 50 videos populated for the search term 'prostate cancer screening' on YT and TK that met inclusion criteria were retrieved in a cache-cleared browser. Three reviewers analysed all videos using validated criteria for the quality of consumer health information (DISCERN and Patient Education Materials Assessment Tool [PEMAT]).
J Urol
April 2023
Yale Cancer Outcomes, Public Policy, and Effectiveness Research Center, New Haven, Connecticut.
Purpose: It is unknown whether compliance with recommended monitoring tests during observation of localized prostate cancer has changed over time.
Materials And Methods: We performed a retrospective cohort study of Medicare beneficiaries diagnosed with low- or intermediate-risk prostate cancer in 2004-2016 who were initially managed with observation for a minimum of 12 months. The primary objective was to examine rates of PSA testing, prostate biopsy, and prostate MRI.
Eur Urol Oncol
April 2023
Academic Urology Unit, Aberdeen University, Aberdeen, UK.
Background: Active surveillance (AS) is recommended for low-risk and some intermediate-risk prostate cancer. Uptake and practice of AS vary significantly across different settings, as does the experience of surveillance-from which tests are offered, and to the levels of psychological support.
Objective: To explore the current best practice and determine the most important research priorities in AS for prostate cancer.
Prostate Cancer Prostatic Dis
December 2023
The Division of Clinical Cancer Genetics, Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA.
Background: Podcasts, or episodic digital audio recordings, represent a novel way to reach large audiences for public education. Genetic evaluation has important implications for prostate cancer (PCa) care but is underutilized. We created a series of five podcasts about PCa genetics and tested their usefulness in raising awareness and providing education to lay audiences.
View Article and Find Full Text PDFEur Urol
May 2023
Department of Anesthesiology, Yale School of Medicine, New Haven, CT, USA; Department of Environmental Health Sciences, Yale School of Public Health, New Haven, CT, USA.
Background: Reducing low-value clinical care is an important strategy to mitigate environmental pollution caused by health care.
Objective: To estimate the environmental impacts associated with prostate magnetic resonance imaging (MRI) and prostate biopsy.
Design, Setting, And Participants: We performed a cradle-to-grave life cycle assessment of prostate biopsy.
Eur Urol Focus
March 2023
Vattikuti Center for Outcomes, Research, Analytics, and Evaluation, Detroit, MI, USA; Vattikuti Urology Institute, Henry Ford Hospital, Detroit, MI, USA. Electronic address:
Int J Cancer
December 2022
Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Androgen deprivation therapy (ADT) has been hypothesized to protect against COVID-19, but previous observational studies of men with prostate cancer on ADT have been inconsistent regarding mortality risk from coronavirus disease 2019 (COVID-19). Using data from the Prostate Cancer data Base Sweden (PCBaSe), we identified a cohort of 114 547 men with prevalent prostate cancer on the start of follow-up in February 2020, and followed them until 16 December 2020 to evaluate the association between ADT and time to test positive for COVID-19. Among men testing positive for COVID-19, we used regression analyses to estimate the association between ADT and risk of COVID-19-related hospital admission/death from any cause within 30 days of the positive test.
View Article and Find Full Text PDFEur Urol Focus
November 2022
The Catherine and Joseph Aresty Department of Urology, USC Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA; European Association of Urology - Young Academic Urologist (EAU-YAU), Arnhem, The Netherlands. Electronic address:
Background: Gender composition among surgical academic leadership, including academic medical journals, disproportionately favors men and may inadvertently introduce a bias. An understanding of the factors associated with gender representation among urologic journals may aid in prioritizing an equitable balance.
Objective: To evaluate female representation on editorial boards of pre-eminent international urologic journals.
Eur Urol Open Sci
March 2022
Department of Urology, Yale School of Medicine, New Haven, CT, USA.
HGG Adv
January 2022
Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA 94158, USA.
Scand J Urol
April 2022
Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Background: Androgens facilitate entrance of the severe acute respiratory syndrome coronavirus 2 into respiratory epithelial cells, and male sex is associated with a higher risk of death from corona virus disease (COVID-19). Androgen deprivation therapy (ADT) could possibly improve COVID-19 outcomes.
Methods: In a case-control study nested in the Prostate Cancer data Base Sweden (PCBaSe) RAPID 2019, we evaluated the association between ADT and COVID-19 as registered cause of death in men with prostate cancer.
PLoS One
October 2021
Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Background: Men have a higher risk of death from COVID-19 than women and androgens facilitate entrance of the SARS-CoV-2 virus into respiratory epithelial cells. Thus, androgen deprivation therapy may reduce infection rates and improve outcomes for COVID-19. In the spring of 2020, Sweden was highly affected by COVID-19.
View Article and Find Full Text PDFJ Urol
November 2021
Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Purpose: We examined the demographic and clinicopathological parameters associated with the time to convert from active surveillance to treatment among men with prostate cancer.
Materials And Methods: A multi-institutional cohort of 7,279 patients managed with active surveillance had data and biospecimens collected for germline genetic analyses.
Results: Of 6,775 men included in the analysis, 2,260 (33.